Johnson & Johnson (JNJ.N)
JNJ.N on New York Stock Exchange
125.85USD
20 Jul 2018
125.85USD
20 Jul 2018
Change (% chg)
$-0.09 (-0.07%)
$-0.09 (-0.07%)
Prev Close
$125.94
$125.94
Open
$125.16
$125.16
Day's High
$126.13
$126.13
Day's Low
$125.12
$125.12
Volume
2,129,211
2,129,211
Avg. Vol
2,148,665
2,148,665
52-wk High
$148.32
$148.32
52-wk Low
$118.62
$118.62
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 2.02 | December | 21 Jul 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 6 | 6 | 7 | 7 |
| (2) OUTPERFORM | 4 | 4 | 4 | 4 |
| (3) HOLD | 9 | 7 | 8 | 8 |
| (4) UNDERPERFORM | 0 | 1 | 1 | 1 |
| (5) SELL | 1 | 2 | 2 | 2 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.30 | 2.45 | 2.41 | 2.41 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 13 | 20,019.20 | 20,310.40 | 19,706.90 | 19,947.90 |
| Quarter Ending Dec-18 | 13 | 20,404.10 | 21,002.50 | 19,802.00 | 20,716.10 |
| Year Ending Dec-18 | 17 | 81,273.20 | 82,392.00 | 80,601.00 | 79,728.90 |
| Year Ending Dec-19 | 19 | 83,480.00 | 86,255.00 | 80,593.00 | 82,851.10 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 17 | 2.02 | 2.09 | 1.83 | 1.93 |
| Quarter Ending Dec-18 | 17 | 1.95 | 2.02 | 1.88 | 1.90 |
| Year Ending Dec-18 | 19 | 8.14 | 8.17 | 8.08 | 7.68 |
| Year Ending Dec-19 | 21 | 8.59 | 8.98 | 7.91 | 8.14 |
| LT Growth Rate (%) | 7 | 7.95 | 9.60 | 4.30 | 6.07 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-18 | 20,390.00 | 20,830.00 | 440.04 | 2.16 |
| Quarter Ending Mar-18 | 19,460.40 | 20,009.00 | 548.56 | 2.82 |
| Quarter Ending Dec-17 | 20,072.50 | 20,195.00 | 122.52 | 0.61 |
| Quarter Ending Sep-17 | 19,282.80 | 19,650.00 | 367.23 | 1.90 |
| Quarter Ending Jun-17 | 18,934.90 | 18,839.00 | 95.86 | 0.51 |
| Earnings (per share) | ||||
| Quarter Ending Jun-18 | 2.07 | 2.10 | 0.03 | 1.44 |
| Quarter Ending Mar-18 | 2.02 | 2.06 | 0.04 | 2.07 |
| Quarter Ending Dec-17 | 1.72 | 1.74 | 0.02 | 0.96 |
| Quarter Ending Sep-17 | 1.80 | 1.90 | 0.10 | 5.46 |
| Quarter Ending Jun-17 | 1.80 | 1.83 | 0.03 | 1.92 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 20,019.20 | 20,306.40 | 20,315.70 | 20,327.20 | 19,947.90 |
| Quarter Ending Dec-18 | 20,404.10 | 20,785.40 | 20,781.70 | 20,802.20 | 20,716.10 |
| Year Ending Dec-18 | 81,273.20 | 81,524.80 | 81,525.20 | 81,536.40 | 79,728.90 |
| Year Ending Dec-19 | 83,480.00 | 83,935.10 | 84,061.20 | 84,078.70 | 82,851.10 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 2.02 | 2.03 | 2.03 | 2.03 | 1.93 |
| Quarter Ending Dec-18 | 1.95 | 1.97 | 1.96 | 1.96 | 1.90 |
| Year Ending Dec-18 | 8.14 | 8.13 | 8.12 | 8.13 | 7.68 |
| Year Ending Dec-19 | 8.59 | 8.58 | 8.58 | 8.58 | 8.14 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-18 | 0 | 10 | 0 | 10 |
| Quarter Ending Dec-18 | 0 | 10 | 0 | 10 |
| Year Ending Dec-18 | 1 | 11 | 1 | 11 |
| Year Ending Dec-19 | 2 | 11 | 2 | 12 |
| Earnings | ||||
| Quarter Ending Sep-18 | 3 | 8 | 3 | 8 |
| Quarter Ending Dec-18 | 2 | 10 | 2 | 10 |
| Year Ending Dec-18 | 9 | 2 | 8 | 2 |
| Year Ending Dec-19 | 5 | 5 | 6 | 5 |
Earnings vs. 
Estimates- Women who sued J&J declare victory after $4.69 billion talc verdict
- Women who sued J&J declare victory after $4.69 bln talc verdict
- Abbott Labs raises 2018 earnings forecast, shares hit record high
- UPDATE 2-Abbott Labs raises 2018 earnings forecast, shares hit record high
- GLOBAL MARKETS-Dollar firms after Fed chair's upbeat remarks, stocks gain